[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $inva

Breaking: $INVA highlighted in upcoming December 2025 FDA PDUFA dates, with strong focus on biotechnology sector catalysts. However, creator activity has seen a significant XX% drop in the last XX hours.

### About $inva
$INVA is a cryptocurrency or digital asset with recent focus on its role in the biotechnology sector.  

### Insights
- $inva posts created is up XXX% from the previous week.

### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$inva/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$inva/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXX  
X Week: XXXXX -XX%  
X Month: XXXXXX +75%  
X Months: XXXXXXX -XX%  
X Year: XXXXXXXXX +126%  
1-Year High: XXXXXXX on 2025-05-21  
1-Year Low: XX on 2025-09-27  

Engagements by network (24h):
Reddit: X
X: XXX

  
  
### Mentions: X (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$inva/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$inva/time-series/posts_active.tsv)  
Current Value: X  
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX +329%  
X Months: XXX -XX%  
X Year: XXXXX +125%  
1-Year High: XXX on 2025-01-19  
1-Year Low: X on 2025-10-09  

Mentions by network (24h):
Reddit: X
X: XX

  
  
### Creators: X (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$inva/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$inva/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $inva in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XX +95%  
X Months: XXX +71%  
X Year: XXXXX +104%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-10-09  

The most influential creators that mention $inva in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | X    | XXXXX     | X     | XX          |

[View More](/list/creators/$inva/100)
  
  
### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$inva/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$inva/time-series/sentiment.tsv)  

Most Supportive Themes:
- Biotechnology Sector Focus: (50%) $INVA is being discussed in the context of the biotechnology sector, particularly concerning FDA approvals and commercial catalysts.
- Upcoming PDUFA Dates: (30%) Multiple posts highlight upcoming PDUFA (FDA approval) dates in December 2025, with $INVA being listed among them.
  
Most Critical Themes:
- Engagement Decline Over X Months: (70%) While recent engagements are up, the 6-month engagement metric shows a significant decrease of -85%.
- Creator Activity Down: (30%) The number of unique social accounts posting about $INVA has decreased by XX% in the last XX hours.
  

### Top $inva Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$INVA Innoviva Balanced Risk/Reward Ahead of 2025 FDA and Commercial Catalysts"  
[Reddit Link](https://redd.it/1pgeioz) [@Merlin8121](/creator/reddit/Merlin8121) 2025-12-07T09:50Z X followers, XX engagements


"December Biotech PDUFA Pulse: 📡 Whats on the FDA Radar $AXGN - Avance Nerve Graft - Approved ✅ $BMY - Breyanzi (lisocabtagene maraleucel) $AGIO - PYRUKYND (Mitapivat) $GSK - BLUJEPA (gepotidacin) $BCRX - ORLADEYO (berotralstat) Oral Granules $MIST - CARDAMYST (etripamil) nasal spray $INVA - Zoliflodacin $ALDX - Reproxalap $GSK - Depemokimab $OMER - Narsoplimab (OMS721) $CYTK - Aficamten $SNY - Tolebrutinib $CORT - Korlym (Relacorilant) $VNDA - Tradipitant $OTLK - ONS-5010 / LYTENAVA (bevacizumab-vikg) $TEVA - TVB-009P (denosumab) $ALVO - AVT06 proposed biosimilar to Eylea (aflibercept) $AMRX"  
[X Link](https://x.com/BiopharmIQ/status/1996624003088503145) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-12-04T16:53Z 28.1K followers, 8060 engagements


"Revenue multiples for all comm'l-stage oncology v non w/1st appr since 1/1/20 & $1-$5B MCs Oncology continues to trade @ lower multiples than non $SNDX v $ARQT $TARS $TGTX $AQRT $MIRM $TARS $TVTX $KNSA $LQDA $APLS $SLNO $MESO $AUPH $INVA $BCRX $ARDX $PGEN $PHAT $XBI $IBB"  
[X Link](https://x.com/NightOwlBiotech/status/1996571879117619504) [@NightOwlBiotech](/creator/x/NightOwlBiotech) 2025-12-04T13:26Z 1662 followers, 1067 engagements


"Comm'l-stage oncology & non-oncology ($100MM+) M&A for 1st approvals since 1/1/13 The odds are overwhelming shareholders are best served via M&A exit post approval. There are few exceptions like $ASND $INSM $CPRX Label extensions $IOVA $GERN $INVA $BCRX $NVAX $PHAR $ARDX $IBB"  
[X Link](https://x.com/NightOwlBiotech/status/1969894711381881118) [@NightOwlBiotech](/creator/x/NightOwlBiotech) 2025-09-21T22:41Z 1663 followers, 2407 engagements